发明名称 |
METHOD FOR THE TREATMENT OF DIABETES MELLITUS |
摘要 |
This disclosure is in the field of medical therapy; in particular, it concerns the use of encapsulated cells in cell therapy. More in particular, this disclosure relates to the second medical use of a composition comprising encapsulated cells. Even more in particular, the disclosure relates to the use of a foreign body, suitable for implantation into a subject at a predefined location, wherein the foreign body comprises cells encapsulated in high-M alginate for inducing or stimulating angiogenesis. |
申请公布号 |
US2016228377(A1) |
申请公布日期 |
2016.08.11 |
申请号 |
US201415022887 |
申请日期 |
2014.09.19 |
申请人 |
BETA-CELL NV |
发明人 |
Bomans Myriam Lea Willy;De Leeuw Mike |
分类号 |
A61K9/48;A61K9/00;A61L27/20;A61L27/58;A61L27/38;A61K35/39;A61L27/54 |
主分类号 |
A61K9/48 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a subject with diabetes mellitus, the method comprising:
implanting a composition into the body of the subject at a predefined location, wherein the composition comprises: aggregates of fetal, newborn, or perinatal pancreatic cells encapsulated in alginate particles with a mannuronic acid content of at least 50%, and a viscosity of 100 mPa·s or less, and wherein the aggregates are smaller than 100 micrometers. |
地址 |
Zellik BE |